EMBL Australia

News this quarter:

• Delegation to EMBL fosters new collaborations
• Position available: Group Leader in Biological Imaging
• Dr Richard Morris to lead research group at UNSW
• Unlocking clues to the cause of Alzheimer’s disease
• Career insights and networking were highlights of PhD Course
• Is Europe calling? Our travel grant applications are open

And more:

• Upcoming events
• Student opportunities
• Job opportunities
• Recent publications
• Get to know Dr Richard Morris

Dr Richard Morris will join our Partner Laboratory Network as a Group Leader, based at the University of New South Wales, early next year.

The mystery of what causes Alzheimer’s disease is a step closer to being solved thanks to an EMBL Australia group leader and his team, who have revealed a genetic link between Alzheimer’s and the endo-lysosomal system, a critical part of biological recycling machinery that maintains the health of brain cells.

EMBL Australia Scientific Head Professor James Whisstock was today awarded an Australian Research Council Australian Laureate Fellowship.

News this quarter:

• Our ACT Node has launched
• Can early antibiotic use make vaccination less effective?
• Life science research to tackle societal challenges
• InsituNet: An app to analyse spatially resolved gene expression data
• Travel grant successes: job offers, collaborations and more

And more:

• Upcoming events
• Student opportunities
• Job opportunities
• Recent publications
• Get to know Dr Robert Weatheritt

EMBL Director General Professor Iain Mattaj shares how his institution’s unique model of giving the most talented young researchers scientific freedom has led to ground-breaking discoveries

Students awarded EMBL Australia travel grants say their international trips led to postdoctoral job offers and enhanced their research, networks and collaboration opportunities.

The Australian National University has joined our Partner Laboratory Network as our first host institute in the ACT.

Chief Scientist Dr Alan Finkel, EMBL Director General Prof Iain Mattaj and EMBL Australia Scientific Head Prof James Whisstock were some of the esteemed speakers to present at the node launch event on 14 June.

Dr Robert Weatheritt is an EMBL Australia Group Leader, based at the Garvan Institute of Medical Research, Sydney.

Research led by EMBL Australia Group Leader David Lynn has shown that, in preclinical animal models, antibiotic exposure in infants impairs their immune responses to five important, routine vaccinations that are administered worldwide.